Thanks.
12 cents is 40 times the current SP and I am having difficulty working out what sort of partnership deal would result in a 4000% valuation increase.
BIT225 as a stand alone drug is partially effective going by the trial results and it is more likely to be used in conjunction with other drugs. That would need another trial undertaken by another party.
That could mean that the other party could use BIT225 but a payment to BIT would be in the range of a few million dollars. Helpful but not likely to increase the SP too much (working capital though I suppose).
- Forums
- ASX - By Stock
- BIT
- Ann: Renounceable Rights Issue
BIT
biotron limited
Add to My Watchlist
0.00%
!
0.2¢

Ann: Renounceable Rights Issue, page-140
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.654M |
Open | High | Low | Value | Volume |
0.2¢ | 0.2¢ | 0.2¢ | $1.606K | 803.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
58 | 39950557 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 17911809 | 22 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
58 | 39950557 | 0.002 |
34 | 68141001 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 17911809 | 22 |
0.004 | 12820969 | 17 |
0.005 | 6690600 | 5 |
0.006 | 1200000 | 2 |
0.007 | 484188 | 1 |
Last trade - 14.19pm 01/07/2025 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Dr. Steven Gourlay, CEO
Dr. Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online